T cells transferred into severe lymphopenic hosts undergo rapid proliferation known as ''endogenous proliferation'' that are distinct from conventional homeostatic proliferation. Unlike homeostatic proliferation, cytokines, such as IL-7 are dispensable, yet TCR:MHC interaction is essential for this process to occur. However, cell types inducing the proliferation have not formally been addressed. In this study, we report that CD11c؉ conventional DCs play irreplaceable roles in inducing endogenous proliferation of both naive and memory phenotype CD4 T cells via TCR-MHC II interaction. By contrast, CD8 T-cell endogenous proliferation was independent of MHC I or CD11c؉ DCs. Interestingly, MHC II was necessary to support naive CD8 T-cell proliferation within MHC I-deficient hosts. Depletion of both B cells and DCs was sufficient to abrogate the proliferation of naive but not of memory CD8 T cells. These results suggest that depending on the T-cell lineages, as well as the differentiation status, different mechanisms control endogenous proliferation, revealing in vivo complexity of T-cell proliferation under lymphopenic conditions.
S
tudies on CD4 T-cell proliferation under lymphopenic conditions have identified at least two mechanistically distinct proliferative T-cell responses, referred to as IL-7-independent ''endogenous proliferation'' (EP; also known as spontaneous proliferation) and IL-7-dependent ''homeostatic proliferation'' (HP) (1, 2) . EP is mainly associated with severe lymphopenia including T cell-deficient TCR␤Ϫ/Ϫ or RagϪ/Ϫ mice, induced by antigens derived from self or microbial antigens, and controlled by memory T-cell repertoire complexity (1, 2) . On the other hand, HP mainly occurs within mild lymphopenia, such as sublethally irradiated recipients. Cytokine competition between T cells and recently identified cytokine-mediated DC modulation are involved during HP (2) (3) (4) .
Both subsets of naive T-cell HP is dramatically inhibited in MHC-deficient irradiated mice, while memory phenotype T-cell HP seems to operate well in these recipients, suggesting that T cells use different mechanisms depending on their differentiation status (5) (6) (7) . EP of naive CD4 T cells was also dependent on TCR-MHC interaction (8) . More recently, it was reported that fast proliferating cells of memory phenotype CD4 T cells that resemble EP were also impaired in sublethally irradiated mice deficient in entire MHC II locus (9) .
APCs involved in CD8 T-cell HP within mild lymphopenic hosts have been examined. Using the CD11c-DTR Tg mice, Jung and colleagues have examined whether DCs are necessary for HP of CD8 T cells in sublethally irradiated mice and found that DT-mediated DC depletion significantly reduces the proliferation (10) . Consistent with this finding, Brocker and colleagues found that transgenic MHC I exclusively expressed on the CD11cϩ DCs is sufficient to induce HP of CD8 T cells in sublethally irradiated mice (11) . However, APCs involved in EP have not been formally examined.
In this report, we investigated the roles of MHC and APC types involved in EP of various T-cell subsets. EP of both naive and memory CD4 T cells was highly dependent on the MHC II expressed on CD11cϩ DCs. By contrast, naive CD8 T-cell EP was independent of MHC I, B cells, and CD11cϩ DCs. Depleting both DCs and B cells abolished EP of naive CD8 T cells. Interestingly, CD8 T cells undergoing EP via interaction with DCs or with B cells displayed dissimilar activation phenotypes. Lymphopenic mice deficient in both MHC I and II failed to support naive CD8 T-cell EP, thus suggesting that CD8 T cells may be induced to undergo EP in response to MHC II when MHC I is not available. By contrast, CD44
high memory phenotype CD8 T cells were still able to undergo proliferation in the absence of both DCs and B cells. Collectively, these results reveal differential requirements of MHC and of DCs during EP of different T-cell subsets in vivo.
Results and Discussion
T-Cell EP Requires Secondary Lymphoid Tissues. T cells that are treated with pertussis toxin (PTX) and transferred into irradiated wild-type recipients, or that are transferred into irradiated LT␣Ϫ/Ϫ mice are unable to proliferate, suggesting that chemokine-dependent entry into the secondary lymphoid tissues, particularly T-cell area, is essential for HP to occur (12) . Whether it applies for EP was examined by transferring PTXtreated CFSE labeled naive T cells into groups of TCR␤Ϫ/Ϫ mice. PTX-pretreated CD4 and CD8 T cells failed to proliferate, while PBS-pretreated T cells displayed robust EP (Fig. S1 A) . FACS sorted naive T cells were also transferred into lethally irradiated LT␣Ϫ/Ϫ or wild-type mice reconstituted with TCR␤Ϫ/Ϫ BM cells. It was previously reported that LT␣Ϫ/Ϫ recipients lack secondary lymphoid tissues except the spleen even after reconstitution with wild-type BM cells (13) . Reconstituted LT␣Ϫ/Ϫ recipients failed to support EP of transferred both naive CD4 and CD8 T cells, while wild-type recipients reconstituted with TCR␤Ϫ/Ϫ BM cells fully promoted EP of both T-cell subsets (Fig. S1B) . Notably, it was previously reported that secondary lymphoid organs and/or CCR7 ligands are essential for the HP of CD4 T cells, but that CD8 T-cell proliferation was unaffected (14, 15) . Given that the only slow proliferation, equivalent to the HP, was examined in these studies, our results suggest that similar to cytokine-dependent HP, EP of naive T cells needs the entry into the secondary lymphoid tissues, mostly lymph nodes rather than the spleen. post transfer. In MHC IIϪ/Ϫ TCR␤Ϫ/Ϫ recipients, CD4 T-cell EP was completely blocked, while CD8 T-cell proliferation was unaffected (Fig. 1A) . Consistent with the CFSE profiles, donor CD4 T-cell recovery in MHC IIϪ/Ϫ TCR␤Ϫ/Ϫ recipients was approximately 1,000-fold lower compared to that in TCR␤Ϫ/Ϫ recipients (Fig. S2 ). CD8 T-cell EP was not reduced within ␤2mϪ/Ϫ TCR␤Ϫ/Ϫ recipients ( Fig. 1 A) , although MHC I expression (K b and D b ) in ␤2mϪ/Ϫ TCR␤Ϫ/Ϫ mice was virtually absent (Fig. S3) . Unexpectedly, CD8 T-cell recovery was also approximately 50-fold lower in MHC IIϪ/Ϫ TCR␤Ϫ/Ϫ recipients (Fig. S2 ) despite the robust proliferation measured by CFSE dilution (Fig. 1 A) . Likewise, CD4 and CD8 T-cell recovery was lower in ␤2mϪ/Ϫ TCR␤Ϫ/Ϫ recipients compared to that in TCR␤Ϫ/Ϫ recipients (Fig. S2) . Of note, CD8 T cells transferred into ␤2mϪ/Ϫ TCR␤Ϫ/Ϫ mice displayed higher Annexin-V staining compared to those transferred into TCR␤Ϫ/Ϫ mice (Fig. S4) , suggesting that T-cell survival may be diminished in the absence of MHC molecules (16) . Depleting NK cells using anti-NK1.1 Ab had no impact on the cell recovery (2.4 ϫ 10 3 from rat IgG and 1.5 Ϯ 0.7 ϫ 10 3 donor T cells in the spleen of anti-NK1.1 Ab treated mice). Donor CD8 T cells express MHC I, and it was reported that the MHC I could provide proliferation signals to ''neighboring'' CD8 T cells and induce proliferation within MHC I-deficient conditions (17) . To test this possibility, we generated MHC IϪ/Ϫ CD8 T cells by reconstituting lethally irradiated B6 mice with ␤2mϪ/Ϫ BM cells. Naive MHC IϪ/Ϫ CD8 T cells were FACS sorted (Fig. S5 ) and then transferred into groups of TCR␤Ϫ/Ϫ ␤2mϪ/Ϫ recipients. As shown in Fig. 1D , MHC IϪ/Ϫ CD8 T cells underwent robust proliferation within ␤2mϪ/Ϫ TCR␤Ϫ/Ϫ recipients, which was comparable to that of MHC Iϩ/ϩ CD8 T cells. Therefore, CD4 T-cell proliferation is dependent on MHC II, while CD8 T-cell proliferation can be induced without MHC I within T-cell-deficient hosts.
To further identify cell types expressing MHC II and inducing CD4 T-cell proliferation we generated BM chimeras. BM cells from TCR␤Ϫ/Ϫ, MHC IIϪ/Ϫ TCR␤Ϫ/Ϫ, and ␤2mϪ/Ϫ TCR␤Ϫ/Ϫ mice were transferred into lethally irradiated TCR␤Ϫ/Ϫ recipients (Fig. 1B) , or alternatively, TCR␤Ϫ/Ϫ BM cells were transferred into lethally irradiated into TCR␤Ϫ/Ϫ, MHC IIϪ/Ϫ TCR␤Ϫ/Ϫ, and ␤2mϪ/Ϫ TCR␤Ϫ/Ϫ recipients ( Fig. 1C) , limiting MHC expression on BM derived (Fig. 1B) or radioresistant (Fig. 1C) cells. CFSE labeled naive T cells were then transferred into the reconstituted mice, and the proliferation was determined 7 days after the transfer. The absence of MHC II on BM derived cells was sufficient to limit CD4 T-cell proliferation (Fig. 1B) , as well as the cell recovery (Fig. S6) . Naive CD4 T-Cell EP Solely Depends on CD11c؉ DCs. We next examined which MHC II-expressing BM-derived cells induce CD4 T-cell EP. Because TCR␤Ϫ/Ϫ mice are used as a model system, there are several cell types that highly express MHC II in these mice, notably DCs and B cells. Since DCs were shown to play important role in CD8 T-cell HP (10, 11), we first tested whether DCs mediate EP. We bred the CD11c-DTR Tg mice onto TCR␤Ϫ/Ϫ background to test this possibility. DT treatment efficiently depleted CD11cϩ DCs in the CD11c-DTR Tg TCR␤Ϫ/Ϫ but not in TCR␤Ϫ/Ϫ mice (Fig. S7) . When naive T cells were transferred into these recipients, CD4 T-cell proliferation was abolished following the DC depletion (Fig. 2) . Given that MHC II-expressing B cells are still abundant in these mice, these results strongly suggest that B cells are dispensable and DCs are the prime APCs inducing CD4 proliferation. Consistent with the impaired proliferation, CD4 T-cell recovery from the DT-treated DTR Tg TCR␤Ϫ/Ϫ recipients was severely impaired (Fig. S8) . Of note, CD8 T-cell proliferation, as well as recovery was partially reduced in the mLN but not in the spleen following the DC depletion ( Fig. 2 and Fig. S8 ).
Plasmacytoid DCs (pDCs) expressing low levels of CD11c are resistant to DT-mediated depletion (19) (Fig. S7) . To test potential involvement of pDCs in the current setting we injected pDC-depleting Ab, PDCA, which efficiently depleted Ly6Cϩ B220ϩ pDCs (Fig. S7) . However, pDC depletion did not alter EP of both naive T-cell subsets (Fig. 2 ) and cell recovery (Fig.  S8) . Depletion of both DC subsets (CD11cϩ conventional DCs and pDCs) by DT/PDCA treatment did not affect naive CD8 T-cell EP compared to DT injected recipients (Fig. 2) . Therefore, naive CD4 T-cell EP solely depends on conventional DCs, while naive CD8 T-cell proliferation can still occur after DC depletion.
B Cells Support Naive CD8 T Cell EP When DCs Are Absent. Unlike CD4 T cells that require DCs through MHC II molecules, another cell type might be involved during CD8 T-cell proliferation via a MHC I-independent manner following DC depletion. To test this possibility, DT-treated CD11c-DTR-Tg TCR␤Ϫ/Ϫ mice transferred with naive T cells were injected with B cell depleting Ab, 18B12 or isotype control Ab, 2B8 to test whether B cells induce CD8 T-cell proliferation when DCs are absent (20) . To our surprise, B cell depletion together with DT treatment abolished naive CD8 T-cell EP in all tested tissues (Fig. 3A) . Isotype control Ab, 2B8 had no effect on the proliferation (Fig.  3A) . It is important to note that 18B12 Ab injection without DT treatment alone had no effect on endogenous T-cell proliferation within TCR␤Ϫ/Ϫ recipients (21) . Consistent with the CFSE profiles, CD8 T-cell recovery was markedly reduced when both DCs and B cells were absent (Fig. S9) . Therefore, these results strongly suggest that either DCs or B cells are capable of inducing naive CD8 T-cell EP in TCR␤Ϫ/Ϫ recipients, which is good contrast with naive CD4 T cells that are solely dependent on the presence of DCs. Because either DCs or B cells can stimulate naive CD8 T cells to proliferate, we next examined the phenotypes of the proliferating CD8 T cells when induced by different APCs. Surface markers associated with memory cells, including CD44, Ly6C, CD122, and CD127 were measured. We found that CD8 T cells stimulated by B cells or DCs displayed different phenotypes (Fig.  3B) ; CD8 T cells from 18B12 Ab treated mice (DC-mediated proliferation) upregulated Ly6C, CD122, and CD127 (Fig. 3B) . By contrast, CD8 T cells from DT treated mice (B cell-mediated proliferation) failed to upregulate Ly6C, CD122, and CD127 (Fig. 3B) . CD8 T cells from DTX (or 2B8 Ab) treated mice rapidly upregulated CD44; however, the CD44 upregulation was not noticed in B cell depleted hosts (Fig. 3B) . It is unclear why the level of memory cell marker expression differs when the proliferation was induced by different APC subsets. Because the phenotypes in this experiment were examined 5 days after transfer and because CD8 T cells undergoing EP within RagϪ/Ϫ recipients fully upregulate CD44 when measured 7 days post transfer (21), it is possible that the differentiation kinetics may vary depending on the APC types. Whether CD8 T cells can develop into memory cells with different characteristics depending on APC subsets remains to be determined. CD8 T-cell IFN␥ expression was similar regardless of APCs (Fig. 3C ), but TNF␣ expression was significantly elevated when CD8 T cells were stimulated by DCs (B cell depleted) (Fig. 3D) . These results suggest that naive CD8 T cells may undergo different differentiation program during EP initiated via an interaction with different types of APCs in vivo.
MHC I-Independent CD8 T-Cell EP Requires MHC II. The finding that naive CD8 T-cell EP failed only when both B cells and DCs were depleted prompted us to test if CD8 T cells may interact with
MHC II within MHC I-deficient settings. It was shown that in CD4Ϫ/Ϫ mice, peripheral CD8 T cells contain MHC IIrestricted T cells (22) . Similarly, it was recently reported that HLA-DR4 alloantigen can be cross-recognized by virus specific CD8 T cells (23) . To test whether CD8 T-cell proliferation seen in MHC I-deficient settings can be induced through an interaction with MHC II molecules, we transferred naive CD8 T cells into TCR␤Ϫ/Ϫ MHC IIϪ/Ϫ ␤2mϪ/Ϫ triple knockout mice. To our surprise, CD8 T-cell EP was abolished when both MHC I and MHC II were absent (Fig. 4A) , which was in contrast to mice deficient in either MHC I or MHC II (Figs. 1 A and 4A) . Consistent with the CFSE profiles, the least cell recovery was observed in triple knockout recipients (Fig. 4B) . Therefore, these results suggest that naive CD8 T cells, unlike naive CD4 T cells, can use either MHC I or MHC II expressed on DCs or on B cells to undergo EP in vivo. This finding may explain why CD8 T cells still proliferate even in BM chimeras where only a minority of the host cells express MHC I (24).
Memory CD8 T-Cell EP Is Independent of B Cells and DCs. Signals involved in CD44 high memory phenotype T-cell HP within sublethally irradiated hosts are different from those involved in naive T cells (5, 6) . Whether EP of memory T cells requires DCs or other APC subsets was examined by transferring CFSE labeled CD44 high memory phenotype T cells into groups of CD11c-DTR Tg TCR␤Ϫ/Ϫ recipients treated with DT. Similar to naive CD4 T cells, CD44 high CD4 T-cell EP was abolished following the DC depletion (Fig. S10A) . Consistent with this and previous report (9) , CD44 high CD4 T cells transferred into TCR␤Ϫ/Ϫ MHC IIϪ/Ϫ mice failed to undergo EP (Fig. S10B) , suggesting that EP of CD4 T cells is dependent on MHC II expressed on CD11cϩ DCs. Similar to naive CD8 T cells, EP of CD44 high CD8 T cells also occurred when DCs were depleted (DTX ϩ 2B8). However, CD44 high CD8 T-cell proliferation was only partially diminished when both DCs and B cells were depleted (DTX ϩ 18B12), which might be induced by cytokines (Fig. 5) . The donor cell recovery was consistent with the CFSE profiles (Fig. S11) . Therefore, signals required for the proliferation differ based on the differentiation status of CD8 T cells.
Our results demonstrate that MHC II expressed on CD11cϩ DCs is the prime inducer of EP of both naive and memory CD4 T cells in vivo. Since MHC II-expressing B cells are incapable of inducing EP, only DCs may deliver a 'full-scale' activation signal possibly via costimulation. Indeed, EP of CD4 T cells requires CD28-mediated costimulation (25, 26) expression in ␤2mϪ/Ϫ TCR␤Ϫ/Ϫ mice was virtually absent when measured by FACS. MHC I expressed on the donor CD8 T cells was previously shown to induce proliferation (17); however, such T-T interaction mediated (and MHC I-dependent) proliferation does not appear to occur in our system, because MHC IϪ/Ϫ CD8 T cells still proliferated in MHC IϪ/Ϫ environments. Instead, naive CD8 T cells appear to recognize MHC II molecules to undergo EP (22, 23) . The frequency of MHC II-restricted CD8 T cells might be too low to be detected, thus they may become noticeable only when encountered MHC I-deficient lymphopenic conditions. It is particularly intriguing to find that CD8 T cells undergoing EP differentiate into different effector phenotype cells depending on APC subsets. CD8 T cells activated primarily by DCs upregulated receptors for homeostatic cytokines and expressed elevated TNF␣ compared to those T cells activated mainly by B cells. These CD8 T cells may differentiate better into long-lived memory CD8 T-cell precursors (28) . Notably, it was previously reported that memory CD8 T cells generated by antigen-mediated stimulation display similar genetic profiles to those generated by homeostatic mechanism (29, 30) . Whether the APC-dependent dichotomy in effector/memory CD8 T-cell differentiation through a homeostatic mechanism results in the generation of different memory subsets should be a topic of interest.
Methods
Mice. C57BL/6, B6 Ly5.1, B6 Thy1.1, B6 TCR␤Ϫ/Ϫ, B6 MHC IIϪ/Ϫ, B6 ␤2mϪ/Ϫ, B6 LT␣Ϫ/Ϫ, B6 OT-I TCR Tg, and B6 CD11c-DTR Tg mice were purchased from Jackson Laboratory. MHC IIϪ/Ϫ TCR␤Ϫ/Ϫ, ␤2mϪ/Ϫ TCR␤Ϫ/Ϫ, MHC IIϪ/Ϫ ␤2mϪ/Ϫ TCR␤Ϫ/Ϫ, CD11c-DTR Tg TCR␤Ϫ/Ϫ mice were bred at the animal facility of the Lerner Research Institute. All animal procedures were conducted according to the guidelines of the Institutional Animal Care and Use Committee.
Cell Sorting and Adoptive Transfer. LN naive T cells were obtained as follows. pLN (axillary, cervical, and inguinal LN) and mesenteric LN were pooled and total T cells were purified by negative selection as described in ref. FACS Analysis. Recipients were killed at the indicated time points after donor T-cell transfer. Peripheral LN, mesenteric LN, and the spleen were harvested, single cell suspension obtained, and stained with anti-CD4 (RM4 -5), anti-CD8 (53-6.7), anti-CD122 (5H4), anti-CD127 (A7R34), anti-CD44 (IM7), CD62L (MEL-14), anti-CD45.1 (A20), or anti-Thy1.1 (HIS51) (all Abs were purchased from eBioscience). Cells were acquired using a FACSCalibur, and analyzed with FlowJo software.
Bone Marrow Reconstitution. BM cells collected from tibia of the donor animals were transferred i.v. into the lethally irradiated (1100 rad) recipients. One milligram of gentamycin was injected into the recipients at days 0 and 2 of BM transfer. Before experiments, BM cell reconstitution was confirmed by FACS analysis. Typically, reconstituted mice were used between 6 and 8 weeks after BM transfer.
Data Analysis. Statistical significance was determined by the Student's t test using the SigmaPlot 9.0 (SPSS Inc.). P Ͻ 0.05 was considered to indicate a significant difference.
